21 May 2013
Keywords: new, pathway, malaria, infection, discovered, cenix, bioscience
Article | 22 September 2008
Cenix BioScience GmbH, a German specialist in advanced RNA interference-based research services, Alnylam Pharmaceuticals, a US RNAi therapeutics company, and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.